➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Colorcon
Moodys
Merck

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

AMMONIA N 13 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Ammonia N 13, and when can generic versions of Ammonia N 13 launch?

Ammonia N 13 is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Health 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Ucla Biomedical, Ucsf Rodiopharm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Wa Univ Sch Med, and Wi Medcl Cyclotron. and is included in twenty-eight NDAs.

The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.

Summary for AMMONIA N 13
Drug patent expirations by year for AMMONIA N 13
Pharmacology for AMMONIA N 13

US Patents and Regulatory Information for AMMONIA N 13

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wi Medcl Cyclotron AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204356-001 Dec 18, 2014 RX No No   Start Trial   Start Trial   Start Trial
3d Imaging Drug AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203779-001 Oct 19, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Precision Nuclear AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204547-001 Aug 14, 2015 RX No No   Start Trial   Start Trial   Start Trial
Ucsf Rodiopharm AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204496-001 Mar 28, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.